Abstract:The efficiency of covalent labeling of a receptor by a photolabile analogue of its natural ligand is dependent on the spatial approximation of the probe and its target. Systematic application of intrinsic photoaffinity labeling to the secretin receptor, a prototypic Family B G protein-coupled receptor, demonstrated reduced efficiency of labeling for amino-terminal and mid-region sites of labeling relative to carboxyl-terminal sites. Reduction of pH from 7.4 to 5.5 and reduction of temperature from 25 °C to 4 °… Show more
“…To improve the nano‐thermotherapy effect, it is necessary to study the ligand‐receptor interaction to gain information about the binding sites that still have binding affinity at high temperatures. [ 8–10 ]…”
Section: Introductionmentioning
confidence: 99%
“…To improve the nano-thermotherapy effect, it is necessary to study the ligand-receptor interaction to gain information about the binding sites that still have binding affinity at high temperatures. [8][9][10] Protein denaturation leads to changes in the binding site structure at high temperatures, and the changes in receptor protein structure with temperature need to be understood to improve the targeted delivery efficiency of NPs. [11][12][13][14] The expression of different proteins on the surface of Hela cells at high temperatures (39-45 C) was…”
The structural change of receptor protein at high temperatures is one of the factors affecting the targeting ability of ligand-installed nanocarriers for combined therapy of hyperthermia and drug delivery. In this study, the binding behaviors and mechanisms of integrin αvβ3 receptor and the arginine-glycine-aspartic acid (RGD) peptide ligand at high temperatures were investigated both theoretically and experimentally. The structural parameters of integrin αvβ3 at different temperatures and the interaction forces between the RGD peptide and integrin αvβ3 at different binding sites were calculated by molecular dynamics simulation. Fourier transform infrared spectroscopy, energy dispersive spectroscopy, ultraviolet-visible absorption spectroscopy, and atomic force microscopy were used to analyze the structural changes of integrin αvβ3 and to measure the ligand-receptor interaction. Results show that the number of hydrogen bonds decreased and the secondary structure of integrin αvβ3 changed with the increase in temperature, indicating the denaturation of integrin αvβ3. The structural stability of the integrin αv subunit was better than that of the integrin β3 subunit at high temperatures. The interaction between the RGD peptide and integrin αvβ3 weakened as the temperature increased because the structure of the integrin αvβ3 binding site became more flexible and the corresponding calcium ions were shed from the binding site. The strongest interaction force was exhibited at the binding site of the integrin β3 subunit at 310 K while it was found at the binding site of the integrin αv subunit at higher temperatures, owing to the smaller structure deformation of the integrin αv subunit.integrin αvβ3-RGD peptide, ligand-receptor interaction force, MD simulation and experimental measurement, protein denaturation, temperature-induced Antitumor drug-loaded nanoparticles (NPs) combined with hyperthermia have been widely investigated in tumor treatment. [1][2][3][4][5] In hyperthermia, the morphology of tumor vascular endothelial cells changes and the tumor cell membrane becomes loose, which is beneficial for NPs transporting to the tissue deeply and crossing over the membrane. [6,7] However, the elevated temperature reduces the targeting efficiency of NPs due to receptor denaturation and binding site inactivation. To improve the nano-thermotherapy effect, it is necessary to study the ligand-receptor interaction to gain information about the binding sites that still have binding affinity at high temperatures. [8][9][10] Protein denaturation leads to changes in the binding site structure at high temperatures, and the changes in receptor protein structure with temperature need to be understood to improve the targeted delivery efficiency of NPs. [11][12][13][14] The expression of different proteins on the surface of Hela cells at high temperatures (39-45 C) was
“…To improve the nano‐thermotherapy effect, it is necessary to study the ligand‐receptor interaction to gain information about the binding sites that still have binding affinity at high temperatures. [ 8–10 ]…”
Section: Introductionmentioning
confidence: 99%
“…To improve the nano-thermotherapy effect, it is necessary to study the ligand-receptor interaction to gain information about the binding sites that still have binding affinity at high temperatures. [8][9][10] Protein denaturation leads to changes in the binding site structure at high temperatures, and the changes in receptor protein structure with temperature need to be understood to improve the targeted delivery efficiency of NPs. [11][12][13][14] The expression of different proteins on the surface of Hela cells at high temperatures (39-45 C) was…”
The structural change of receptor protein at high temperatures is one of the factors affecting the targeting ability of ligand-installed nanocarriers for combined therapy of hyperthermia and drug delivery. In this study, the binding behaviors and mechanisms of integrin αvβ3 receptor and the arginine-glycine-aspartic acid (RGD) peptide ligand at high temperatures were investigated both theoretically and experimentally. The structural parameters of integrin αvβ3 at different temperatures and the interaction forces between the RGD peptide and integrin αvβ3 at different binding sites were calculated by molecular dynamics simulation. Fourier transform infrared spectroscopy, energy dispersive spectroscopy, ultraviolet-visible absorption spectroscopy, and atomic force microscopy were used to analyze the structural changes of integrin αvβ3 and to measure the ligand-receptor interaction. Results show that the number of hydrogen bonds decreased and the secondary structure of integrin αvβ3 changed with the increase in temperature, indicating the denaturation of integrin αvβ3. The structural stability of the integrin αv subunit was better than that of the integrin β3 subunit at high temperatures. The interaction between the RGD peptide and integrin αvβ3 weakened as the temperature increased because the structure of the integrin αvβ3 binding site became more flexible and the corresponding calcium ions were shed from the binding site. The strongest interaction force was exhibited at the binding site of the integrin β3 subunit at 310 K while it was found at the binding site of the integrin αv subunit at higher temperatures, owing to the smaller structure deformation of the integrin αv subunit.integrin αvβ3-RGD peptide, ligand-receptor interaction force, MD simulation and experimental measurement, protein denaturation, temperature-induced Antitumor drug-loaded nanoparticles (NPs) combined with hyperthermia have been widely investigated in tumor treatment. [1][2][3][4][5] In hyperthermia, the morphology of tumor vascular endothelial cells changes and the tumor cell membrane becomes loose, which is beneficial for NPs transporting to the tissue deeply and crossing over the membrane. [6,7] However, the elevated temperature reduces the targeting efficiency of NPs due to receptor denaturation and binding site inactivation. To improve the nano-thermotherapy effect, it is necessary to study the ligand-receptor interaction to gain information about the binding sites that still have binding affinity at high temperatures. [8][9][10] Protein denaturation leads to changes in the binding site structure at high temperatures, and the changes in receptor protein structure with temperature need to be understood to improve the targeted delivery efficiency of NPs. [11][12][13][14] The expression of different proteins on the surface of Hela cells at high temperatures (39-45 C) was
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.